Burstein G R, Gaydos C A, Diener-West M, Howell M R, Zenilman J M, Quinn T C
Department of Molecular Microbiology and Immunology, Johns Hopkins University, Baltimore, MD 21205, USA.
JAMA. 1998 Aug 12;280(6):521-6. doi: 10.1001/jama.280.6.521.
Adolescents are at highest risk for infection with Chlamydia trachomatis, an important preventable cause of pelvic inflammatory disease and subsequent tubal factor infertility in US women. Current guidelines for delivery of adolescent primary care services recommend yearly chlamydia screening for those adolescent females considered to be at risk.
To describe the epidemiology of prevalent and incident chlamydia infection among adolescent females to assess the appropriate interval for chlamydia screening and to define risk factors that would identify adolescent females to target for screening.
Prospective longitudinal study.
A consecutive sample of 3202 sexually active females 12 through 19 years old making 5360 patient visits over a 33-month period, January 1994 through September 1996.
Baltimore, Md, family planning, sexually transmitted disease, and school-based clinics.
Testing for C trachomatis by polymerase chain reaction.
Prevalence and incidence of C trachomatis infections; predictors of positive test result for C trachomatis.
Chlamydia infection was found in 771 first visits (24.1%) and 299 repeat visits (13.9%); 933 adolescent females (29.1%) had at least 1 positive test result. Females who were 14 years old had the highest age-specific chlamydia prevalence rate (63 [27.5%] of 229 cases; P=.01). The chlamydia incidence rate was 28.0 cases per 1000 person-months (95% confidence interval, 24.9-31.5 cases). The median time was 7.2 months to a first positive chlamydia test result and 6.3 months to a repeat positive test result among those with repeat visits. Independent predictors of chlamydia infection--reason for clinic visit, clinic type, prior sexually transmitted diseases, multiple or new partners, or inconsistent condom use-failed to identify a subset of adolescent females with the majority of infections.
A high prevalence and incidence of C trachomatis infection were found among adolescent females. We, therefore, recommend screening all sexually active adolescent females for chlamydia infection every 6 months, regardless of symptoms, prior infections, condom use, or multiple partner risks.
在美国女性中,青少年感染沙眼衣原体的风险最高,沙眼衣原体是盆腔炎及后续输卵管因素导致不孕的重要可预防病因。当前青少年初级保健服务提供指南建议,对那些被认为有风险的青少年女性每年进行沙眼衣原体筛查。
描述青少年女性中沙眼衣原体现患感染和新发感染的流行病学特征,以评估沙眼衣原体筛查的合适间隔时间,并确定可识别需进行筛查的青少年女性的危险因素。
前瞻性纵向研究。
1994年1月至1996年9月的33个月期间,连续抽取3202名12至19岁的性活跃女性,她们共就诊5360次。
马里兰州巴尔的摩的计划生育、性传播疾病及学校诊所。
采用聚合酶链反应检测沙眼衣原体。
沙眼衣原体感染的患病率和发病率;沙眼衣原体检测阳性结果的预测因素。
在771次初诊(24.1%)和299次复诊(13.9%)中发现沙眼衣原体感染;933名青少年女性(29.1%)至少有1次检测结果呈阳性。14岁女性的沙眼衣原体年龄别患病率最高(229例中有63例[27.5%];P = 0.01)。沙眼衣原体发病率为每1000人月28.0例(95%置信区间,24.9 - 31.5例)。初诊首次沙眼衣原体检测结果呈阳性的中位时间为7.2个月,复诊再次检测结果呈阳性的中位时间为6.3个月。沙眼衣原体感染的独立预测因素——就诊原因、诊所类型、既往性传播疾病、多个或新的性伴侣以及避孕套使用不一致——未能识别出大多数感染的青少年女性亚组。
在青少年女性中发现沙眼衣原体感染的患病率和发病率较高。因此,我们建议对所有性活跃的青少年女性每6个月进行一次沙眼衣原体感染筛查,无论有无症状、既往感染情况、避孕套使用情况或多个性伴侣风险。